Day: November 7, 2024

Nyxoah Reports Third Quarter Financial and Operating Results

REGULATED INFORMATION Nyxoah Reports Third Quarter Financial and Operating Results FDA approval on track for first quarter 2025, U.S. commercial team build out in progress Company fully funded with cash until mid 2026 Mont-Saint-Guibert, Belgium – November 6, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough

Search Here

Popular News

Fury and Joshua to Face Off in Cardiff Heavyweight Showdown

Cardiff:A highly anticipated heavyweight boxing match between Tyson Fury and Anthony Joshua is set to take place on Friday, December 11, at Principality Stadium in Cardiff, Wales, United Kingdom.

According to Saudi Press Agency, Turki Alalshikh, Cha…

MENU

CATEGORIES